Nuclear Factor-κB-inducible Death Effector Domain-containing Protein Suppresses Tumor Necrosis Factor-mediated Apoptosis by Inhibiting Caspase-8 Activity
Open accessThe DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.
Abstract
Activation of the transcription factor nuclear factor-kappa B (NF-kappa B) has been found to play an essential role in the inhibition of tumor necrosis factor (TNF)-mediated apoptosis. NF-kappa B regulates several antiapoptotic molecules including inhibitors of apoptosis, Bcl-2 family proteins (A1 and Bcl-X(L))(,) and IEX-IL. Here we report that the expression of a small death effector domain (DED)-containing protein, NDED (NF-kappa B-inducible DED-containing protein), depends on the activation of NF-kappa B. The inhibition of NF-kappa B by I kappa B alpha, a natural inhibitor of NF-kappa B, suppressed NDED mRNA expression induced by TNF. The restoration of NDED in NF-kappa B null cells inhibited TNF-induced apoptosis. Intriguingly, unlike the caspase-8 inhibitor cellular FADD-like interleukin-1 beta converting enzyme-inhibitory protein (c-FLIP), NDED suppressed TNF-mediated apoptosis by inhibiting TNF-induced caspase-8 enzymatic activity but not the processing of caspase-8. Furthermore, NDED could not inhibit etoposide-mediated apoptosis that is independent of caspase-8 activation. Our results provide the first demonstration that NF-kappa B transcriptionally induces the DED-containing protein to suppress TNF-mediated apoptosis by inhibiting caspase-8 activity, which offers new insight into the antiapoptotic mechanism of NF-kappa B.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Of note, CFLAR (the gene encoding c-FLIP) is under direct transcriptional control by NF-κB, which largely contributes to pro-survival TNFR1 signaling in specific circumstances (see below) [287, 296, 305].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [305]
Citations
Cites
Green, D. R., & Reed, J. C. (1998) · Science · doi:10.1126/science.281.5381.1309 · Cited by 8,965
Thornberry, N. A., & Lazebnik, Y. (1998) · Science · doi:10.1126/science.281.5381.1312 · Cited by 6,887
Death Receptors: Signaling and Modulation
Ashkenazi, A., & Dixit, V. M. (1998) · Science · doi:10.1126/science.281.5381.1305 · Cited by 5,866
NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
Ghosh, S., May, M. J., & Kopp, E. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.225 · Cited by 5,182
Cleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis
Li, H., Zhu, H., Xu, C.-J., & Yuan, J. (1998) · Cell · doi:10.1016/s0092-8674(00)81590-1 · Cited by 4,445
Luo, X., Budihardjo, I., Zou, H., Slaughter, C., & Wang, X. (1998) · Cell · doi:10.1016/s0092-8674(00)81589-5 · Cited by 3,626
An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death
Beg, A. A., & Baltimore, D. (1996) · Science · doi:10.1126/science.274.5288.782 · Cited by 3,047
Muzio, M., Chinnaiyan, A. M., Kischkel, F. C., O'Rourke, K., Shevchenko, A., Ni, J., Scaffidi, C., Bretz, J. D., Zhang, M., Gentz, R., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81266-0 · Cited by 3,046
Wang, C.-Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V., & Baldwin, A. S. (1998) · Science · doi:10.1126/science.281.5383.1680 · Cited by 2,711
Self-citationTNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB
Wang, C.-Y., Mayo, M. W., & Baldwin, A. S. (1996) · Science · doi:10.1126/science.274.5288.784 · Cited by 2,617
Self-citation
Research works printed but not linked: 2
- Duckett, 1997, Biochim. Biophys. Acta, 1332, R45
- Mayo, 2000, Biochim. Biophys. Acta, 1470, M55
Cited by
Items 101–125 of 125
Yu, B., Xu, L. Z., Cai, M. M., Zhang, D., & Li, S. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.8639 · Cited by 6
“TNFAIP8 is associated with enhanced cell survival and inhibition of proapoptotic enzymes, including caspase-8 and caspase-3, and depends on the activation of nuclear factor-κ B and TNF-α in human cancer cells (7).”
The role of cytokines in ovarian cancer drug resistance
Wang, L., Zang, Y., Dejenie, R., Bing, J., Dong, S., Zhang, Y., Zhu, Y., & Li, J. (2025) · International Journal of Cancer · doi:10.1002/ijc.70099 · Cited by 6
“82,83 Additionally, TNFAIP8 expression is markedly increased in platinum-resistant tumors versus normal ovarian tissue, indicating that TNFAIP8 is associated with ovarian cancer drug resistance.”
Kumari, R., Palaniyandi, S., Strattan, E., Huang, T., Köhler, K., Jabbour, N., Dalland, J., Du, J., Kesler, M., Chen, Y. H., et al. (2019) · Transplantation · doi:10.1097/tp.0000000000003013 · Cited by 6
Umasuthan, N., Revathy, K. S., Whang, I., Kim, E., Oh, M., Jung, S., Lee, J., Park, H., & Lee, J. (2014) · Gene · doi:10.1016/j.gene.2014.02.047 · Cited by 5
“There is evidence for the induction of TNFAIP8 transcription by NF-κB activation under different pathophysiological conditions (Kumar et al., 2000a; You et al., 2001).”
BackgroundLu, J., Tian, Z., Shofer, F. S., Qin, L., Sun, H., & Zhang, Y. (2024) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0000000000002488 · Cited by 4
“10,11 TIPE1, on the contrary, interacts with Rac1 and inhibits p65 and c-Jun N-terminal kinase signaling, which increases caspase-mediated apoptosis.”
The SOX11:SMARCA4 complex is a driver of oncogenic transcriptional programs in mantle cell lymphoma
Bolòs, A. D., Carreras-Caballé, M., Sureda-Gómez, M., Rodríguez, M.-L., Charalampopoulou, S., Alberó, R., Maiqués-Díaz, A., Playà-Albinyana, H., Clot, G., López, C., et al. (2025) · Blood Cancer Journal · doi:10.1038/s41408-025-01333-6 · Cited by 3
“NIK transcriptionally activates the BCL2 pathway, facilitating resistance to apoptosis during tumor development [27].”
Chen, L., Wu, J., Yang, H., Liu, J., & Yu, Y. (2025) · Cardiovascular Toxicology · doi:10.1007/s12012-025-10061-z · Cited by 4
“When TNF-α binds to TNFI/II receptors on the cell surface, it causes TIPE protein expression, leading to activation and nuclear localization of NF-κB and binding to target genes [22, 23].”
Sellin, M., Koentopp, L. M., Bader, R., & Jonitz‐Heincke, A. (2025) · Cell Biology and Toxicology · doi:10.1007/s10565-025-10087-7 · Cited by 3
“NF-κB plays an important role in the inhibition of TNF-initiated apoptosis (You et al. 2001).”
A “light” touch on PI3K to interrogate cancer drug resistance
Wang, T., Ke, Y., & Zhou, Y. (2022) · Cell chemical biology · doi:10.1016/j.chembiol.2022.11.005 · Cited by 3
Supplementary Material and Methods
Rosato, P. C., Anastasiadou, E., Garg, N., Lenze, D., Boccellato, F., Vincenti, S., Severa, M., Coccia, E. M., Bigi, R., Cirone, M., et al. (2012) · Cited by 3
Jiang, L., Yao, Y.-M., Zhu, X., Dong, N., Zhang, Q. H., Yu, Y., & Sheng, Z.-Y. (2013) · European Journal of Inflammation · doi:10.1177/1721727x1301100109 · Cited by 2
Li, J., Xiong, J., Lin, W., Zhang, M., Yi, J., & Liu, L. (2023) · The Journal of Gene Medicine · doi:10.1002/jgm.3569 · Cited by 2
Fas—More Than an Apoptosis Inducer
Wajant, H. (2007) · Springer eBooks · doi:10.1007/0-387-34573-6_6 · Cited by 1
Lichtner, S., Schunck, K., Frey, J., Osti, J., Dannheimer, S., Schnur, S., Lehr, C., Schneider, M., & Hittinger, M. (2025) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2025.114869 · Cited by 1
Day, T. F. (2015) · DigitalGeorgetown (Georgetown University Library) · Cited by 1
Structural insight into TIPE1 functioning as a lipid transfer protein
Cao, S., Zhang, Y., Jiang, H., Hou, X., & Wang, W. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2187641
“This family contains four members: TNFAIP8, TNFAIP8-like 1 (TIPE1), TNFAIP8-like 2 (TIPE2), and TNFAIP8-like 3 (TIPE3) proteins (Lou & Liu, 2011; You et al., 2001) .”
Drastichová, Z., Rudajev, V., Pallag, G., & Novotny, J. (2021) · Figshare · doi:10.6084/m9.figshare.13788297
Drastichová, Z., Rudajev, V., Pallag, G., & Novotny, J. (2021) · Figshare · doi:10.6084/m9.figshare.13788318
Drastichová, Z., Rudajev, V., Pallag, G., & Novotny, J. (2021) · Figshare · doi:10.6084/m9.figshare.13788291
Drastichová, Z., Rudajev, V., Pallag, G., & Novotny, J. (2021) · Figshare · doi:10.6084/m9.figshare.13788321
Drastichová, Z., Rudajev, V., Pallag, G., & Novotny, J. (2021) · Figshare · doi:10.6084/m9.figshare.13788303
Role of the MDM2/p53 axis in regulating cisplatin response in tumor cells
Rajabloo, Y., Akhlaghipour, I., Taghehchian, N., & Moghbeli, M. (2026) · Clinical & Translational Oncology · doi:10.1007/s12094-026-04389-3 · Cited by 1
“These mechanisms promote cell proliferation and survival by impeding the caspase-3 and caspase-8 activities [60–62].”
Niture, S. K., Wu, D. H., & Seneviratne, D. S. (2026) · Biomedicines · doi:10.3390/biomedicines14112470
Metadata
- Authors
- You, Z., Ouyang, H., Lopatin, D., Polver, P. J., & Wang, C.-Y.
- Affiliations
- University of Michigan (US)
- University of Minnesota (US)
- Corresponding author
- Wang, Cun-Yu
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2001-07
- Volume
- 276
- Issue
- 28
- Pages
- 26398-26404
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2077127766
- Cited by
- 127
- References
- 48
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 1 · 2023: 2 · 2022: 3 · 2021: 9 · 2020: 9 · 2019: 8 · 2018: 8 · 2017: 3 · 2016: 8 · 2015: 3 · 2014: 3 · 2013: 9 · 2012: 7
- FWCI
- 2.90
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 7033 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01de013788-03)
- National Institute of Dental and Craniofacial Research (R01DE13848, R01DE013848, R01-DE13788)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- NF-κB, TNF-α, caspase-8 inhibition, anti-apoptotic mechanisms, IκBα, c-FLIP, transcriptional regulation, etoposide-induced apoptosis
- MeSH terms
- Humans, Tumor Cells, Cultured, Tumor Necrosis Factor-alpha, Signal Transduction, NF-kappa B, Apoptosis, Caspases, Caspase 8, Caspase 9
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.